Therapeutic Potential of Human Umbilical Cord Blood Derived Mesenchymal Stem Cells in Murine Model of Hepatic Schistosomiasis

Article 15Volume 10, Issue 2, June 2020, Page 151-162  

Document Type: Original Article

DOI: 10.21608/AEJI.2020.26363.1061

Authors

Mohammad Abd-El Rehiem Bebars1Hanan Hussein Kamel1Hala Gabr2Heba Abdel Kader Aminou1Lobna Shash3Shimaa Essam Al-din Mohammed1Ayman Ashkar email  4

1Medical Parasitology department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

2Clinical Pathology department, Faculty of Medicine, Cairo University, Cairo, Egypt

3Pathology department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

41st: Medical Parasitology department, Faculty of Medicine ,Ain Shams University, Cairo, Egypt. 2nd: college of medicine - University of Bisha - KSA

Abstract

Background and Aim: The pathogenesis of schistosomiasis is mainly due to the host’s immune response against Schistosoma eggs trapped in tissues causing a granulomatous reaction. Recently, stem cell therapy has drawn much attention due to their potential for self-renewal and differentiation. The present study was designed to investigate the regenerative and antifibrotic potential of Human Umbilical Cord Blood derived Mesenchymal Stem Cells (HUCB-MSCs) in hepatic granuloma due to schistosomiasis mansoni in the experimental murine model.
Material and Methods: Swiss Albino mice (n=70) were divided into 3 groups; Group A: 30 mice infected with S. mansoni cercariae and subjected to intrahepatic injection of HUCB-MSCs by a single dose of 1 million HUCB-MSCs at 12 weeks post infection (wpi), G (A1): 10 mice sacrificed at 16 (wpi), G (A2):10 mice sacrificed at 18 (wpi), G (A3): 10 mice sacrificed at 20 (wpi). Group B: 30 mice infected with S. mansoni cercariae (positive control), G (B1):10 mice sacrificed at 16 (wpi), G (B2):10 mice sacrificed at 18 (wpi), G (B3):10 mice sacrificed at 20 (wpi). Group C: 10 uninfected mice (negative control).
Results: Treatment with HUCB-MSCs, showed an improvement in the histopathological picture of the liver with diminution in the size of granulomas and the overall fibrotic content. Hyperplasic changes in intrahepatic biliary radicals obviously decreased in test groups.
Conclusion: The human umbilical cord blood-derived MSCs are promising and effective therapy for the treatment of diseased or damaged liver tissues.

Keywords

Cord blood-derived MSCsSchistosomiasis mansoniLiver fibrosisImmunohistochemistry

Main Subjects

Endemic medicine